How many insider trades does FilingIQ track for PMVP?

FilingIQ tracks 301 Form 4 insider transactions for PMVP (PMV Pharmaceuticals, Inc.), covering filings from Sep 25, 2020 onwards. 4 of those were filed in the last 90 days.

Are PMVP insiders net buyers or net sellers?

Across the full Form 4 history for PMVP, 10 transactions (3%) were open-market purchases and 181 (60%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PMVP insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is PMVP in?

PMV Pharmaceuticals, Inc. (PMVP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $86.73M.

PMVP insider trading

NasdaqGS Healthcare

PMV Pharmaceuticals, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

301

Last 90 days

Buys / sells

3% / 60%

Market cap

$86.73M

About PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.

Company website: www.pmvpharma.com

PMVP insider activity at a glance

FilingIQ has scored 301 insider transactions for PMVP since Sep 25, 2020. The most recent filing in our index is dated Mar 5, 2026.

Across the full history, 10 open-market purchases and 181 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PMVP insider trades is 53.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PMVP trades on FilingIQ Raw filings on SEC EDGAR

Latest PMVP Form 4 filings

Mack David Henry President and CEO

S Jul 1, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding PMVP

Euclidean Capital LLC

$16.13M · 3.5% of AUM

Frequently asked

How many insider trades does FilingIQ track for PMVP?: FilingIQ tracks 301 Form 4 insider transactions for PMVP (PMV Pharmaceuticals, Inc.), covering filings from Sep 25, 2020 onwards. 4 of those were filed in the last 90 days.
Are PMVP insiders net buyers or net sellers?: Across the full Form 4 history for PMVP, 10 transactions (3%) were open-market purchases and 181 (60%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PMVP insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PMVP in?: PMV Pharmaceuticals, Inc. (PMVP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $86.73M.

Methodology & sources

Every PMVP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.